News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
HANSOH PHARMA (03692.HK) Transfers Development and Commercialization Rights of KiOmedine One to HENGRUI PHARMA (01276.HK) for RMB131M
HANSOH PHARMA (03692.HK) announced that its wholly-owned subsidiary (the original licensee), which had obtained an exclusive license from KiOmed to develop and commercialize KiOmed...
Reset
Send
The window will close in 5 seconds
HANSOH PHARMA (03692.HK) Transfers Development and Commercialization Rights of KiOmedine One to HENGRUI PHARMA (01276.HK) for RMB131M
Close
Recommend
3
Positive
4
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get Level 1 Real-Time Streaming!

HANSOH PHARMA (03692.HK)  -0.280 (-0.768%)    Short selling $48.32M; Ratio 20.126%   announced that its wholly-owned subsidiary (the original licensee), which had obtained an exclusive license from KiOmed to develop and commercialize KiOmedine One for the treatment of osteoarthritis in Mainland China, Hong Kong, Macau and Taiwan, has entered into a novation agreement to transfer all rights, responsibilities and obligations to HENGRUI PHARMA (01276.HK)  -0.400 (-0.578%)    Short selling $92.68M; Ratio 19.987%   for RMB131 million. (sl/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-13 16:25.)

Related News M Stanley: HENGRUI PHARMA (01276.HK) Forms USD15.2B Strategic Partnership with Bristol-Myers Squibb Company (BMY.US) to Accelerate Globalization

Auto-translated by AI
View Original Text
This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.